PTEN and cancer: Intriguingly, the proposed p85α-binding site on PTEN also overlaps with a PTEN surface that is frequently mutated in cancers (in 30% of the missense mutations of the phosphatase domain), suggesting that some of these PTEN mutants may disrupt association with p85α therefore decreasing PTEN protein stability and activity.